** Elevance's ELV.N shares rise 6.4% to $416.03 premarket
** Insurer beats Q4 profit estimates helped in part by lower-than-expected spending on medical care for its customers
** Company reports Q4 adjusted profit of $3.84 per share, beating estimates of $3.80 per share as per data compiled by LSEG
** Reports Q4 medical loss ratio — the percentage of premiums spent on medical care — of 92.4%, compared with analysts' estimates of 92.65%
** Stock had fallen 21.8% in 2024
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。